InvestorsHub Logo

iwantin2

12/24/12 8:24 AM

#25734 RE: Solantey #25729

Keep waiting for a dip bud.. GLTY!

familyof5

12/24/12 8:26 AM

#25737 RE: Solantey #25729

Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None



"AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012."
Solantey




"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213





"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"